ProPhase Labs, Inc. Contractual Obligation, to be Paid, Year Five
ProPhase Labs, Inc. (PRPH) had Contractual Obligation, to be Paid, Year Five of $675.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity › Contractual Obligation, to be Paid, Year Four and Five
us-gaap:ContractualObligationDueInFifthYear · last filed 2022-03-31
- 2021-12-31: Contractual Obligation, to be Paid, Year Five $675.00K.
- 2015-03-31: Contractual Obligation, to be Paid, Year Five $0.00.
- 2014-12-31: Contractual Obligation, to be Paid, Year Five $0.00.
- 2014-09-30: Contractual Obligation, to be Paid, Year Five $0.00.
| Period end | Contractual Obligation, to be Paid, Year Five |
|---|---|
| 2021-12-31 | $675.00K 10-K · filed 2022-03-31 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-13 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-27 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 |
| 2013-12-31 | $0.00 10-K · filed 2014-03-27 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |